MannKind Corporation (MNKD) CEO Michael Castagna Presents at Cantor Global Healthcare 2021 Conference (Transcript)Seeking Alpha • 09/27/21
MannKind Corporation (MNKD) CEO Michael Castagna Presents at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit (Transcript)Seeking Alpha • 09/22/21
MannKind Corporation (MNKD) CEO Michael Castagna Presents at H.C. Wainwright 23rd Annual Global Investment Brokers Conference (Transcript)Seeking Alpha • 09/13/21
MannKind Corporation to Participate in H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/07/21
MannKind Corporation (MNKD) CEO Michael Castagna on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/12/21
NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respiratory ConditionsPRNewsWire • 08/04/21
MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (aviptadil) Based On The Technosphere® PlatformPRNewsWire • 08/04/21
MannKind Corporation to Hold 2021 Second Quarter Financial Results Conference Call on August 11, 2021GlobeNewsWire • 08/04/21
INDYCAR Driver Conor Daly To Share His Personal Diabetes Story And Race Go-Karts With Local Youth On Wednesday, August 4thPRNewsWire • 07/29/21
MannKind (MNKD) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/28/21
Policy Change Allows Approval For Medicare Patients Living With Diabetes To Use Both Afrezza® And Continuous Glucose Monitoring Devices Beginning July 18PRNewsWire • 06/28/21
MannKind Presents Two Posters At American Diabetes Association's Virtual 81st Scientific Sessions, June 25-29PRNewsWire • 06/25/21
MannKind And United Therapeutics Achieve A Major Milestone In The Development Of Tyvaso DPI™ With New Drug Application Acceptance From The FDAPRNewsWire • 06/16/21
MannKind - United Therapeutics' Formulated Treprostinil Under FDA Review For Pulmonary HypertensionBenzinga • 06/16/21
MannKind Corporation (MNKD) Management Presents at Lytham Partners Summer 2021 Investor Conference (Transcript)Seeking Alpha • 06/14/21
MannKind and Thirona Bio Join Forces to Evaluate Potential Inhaled Therapy for Fibrotic Lung DiseasesGlobeNewsWire • 06/10/21